Is Viking Therapeutics Stock Really Heading Higher
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Explore options for retirement accounts at 50. Make informed choices to secure your financial future.
24,046 articlesInvestors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
A reserves-and-resources update put Coeur Mining back in focus, with millions of ounces of gold on the books and a pr...
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
Bitcoin trades in a tight range after a sharp pullback, with big holders keeping their powder dry while retail buyers...
A wave of fresh analyst upgrades and price-target bumps hits NVIDIA, Alphabet, and other big names as markets start t...
A pro-Ripple lawyer’s critique of a potential Sam Bankman-Fried pardon is shaping XRP traders’ views as price targets...
A growing AI marketing platform is courting retail investors with a Reg A+ round at $0.85 per share, pitching a scala...
Investing in Nexpoint Residential (NXRT) hinges on understanding earnings beyond headline numbers. This guide breaks ...
Palantir sits around $130 as Michael Burry’s $46 valuation challenge re-emerges, forcing a sharper look at growth, ma...
The AI inference market could surge to about $255 billion by 2030 as demand for real-time AI services climbs. Learn w...
As Florida lawmakers race to finish a two-week session, a dispute over accessory dwelling unit rules could stall the ...
Dorman's 2025 earnings narrative hinges on aftermarket demand, margins, and strategic bets. This guide breaks down wh...